La tobramicina - Farmacologia clinica e chemioterapia

Journal of Chemotherapy

Volumn 8, Issue SUPPL. 1, 1996, Pages 3-30

  Periti, P ^a  

^a NONE

Author keywords

Aminoglycosides; Drug dosing; Lower respiratory tract infection; Tobramycin; Toxicity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; OTOTOXICITY; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; RESPIRATORY TRACT INFECTIONS; TOBRAMYCIN;

EID: 0029866006     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Schentag JJ. Aminoglycoside pharmacokinetics as a guide to therapy and toxicology. In: "The Aminoclycosides; Microbiology, Clinical Use, and Toxicology" (Whelton A, Neu HC, Eds). Dekker Inc., New York and Basel 1982: 143-167.
2. Periti P, Novell! A. Antibioticii aminoglucosidici. Antibioticoterapia Pratica 1988; 1: 87-97.
3. Novell! A, Periti P. Valutazione farmacologica clincia della tobramicina nell'ambito degli antibiotici aminoglucosidici. Farm Ter 1994; 11: 59-91.
4. Jones RN. Isepamicin (SCH 21426, 1-N-MAPA gentamicin B): microbiological characteristics including antimicrobial potency and spectrum of activity. J Chemother 1995; 7 (Suppl 2): 7-16.